Patsy Newitt

Four updates from private equity companies from the last 14 days:

ASC surgery volume is projected to grow 25 percent in the next decade, according to an analysis from Sg2 Healthcare Intelligence, a Vizient company focused on market analytics and insights. 

The Federal Trade Commission has taken aim against a private-equity firms' healthcare deal in a move regulators say could spell trouble for other healthcare agreements the agency deems anticompetitive,  The Wall Street Journal reported recently.

Thirty percent of specialist physicians invested in a stock or company that turned out badly, according to Medscape's "Physician Wealth & Debt Report 2022."

Anesthesiologists in the East and South saw sizable drops in their median wages from 2021 to 2022, according to a June blog post from Tony Mira, Anesthesia Business Consultants' president and CEO.

Infectious diseases is the specialty with the most physicians most likely to report net worth under $500,000, according to Medscape's "Physician Wealth & Debt Report 2021."

Tenet Healthcare is planning a hospital and ASC in Port St. Lucie, Fla., The Palm Beach Post reported June 17. 

A Florida physician, pharmacist and Navy veteran lost the appeal of their conviction in a $4.4 million Tricare fraud scheme, according to a June 20 article in JDSupra from the law firm Burr & Forman. 

Recent government actions involving ASC-anesthesia provider arrangements point to a need to carefully vet these partnerships, according to a June 20 article in JDSupra from the law firm Waller Lansden Dortch & Davis. 

Plastic surgery is the specialty with the most physicians most likely to report net worth exceeding $5 million, according to Medscape's "Physician Wealth & Debt Report 2021."